These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9154250)

  • 81. Dysthymia in a cross-cultural perspective.
    Gureje O
    Curr Opin Psychiatry; 2011 Jan; 24(1):67-71. PubMed ID: 21088583
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Psychosocial impact of dysthymia: a study among married patients.
    Subodh BN; Avasthi A; Chakrabarti S
    J Affect Disord; 2008 Jul; 109(1-2):199-204. PubMed ID: 18164766
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The categorisation of dysthymic disorder: can its constituents be meaningfully apportioned?
    Rhebergen D; Graham R; Hadzi-Pavlovic D; Stek M; Friend P; Barrett M; Parker G
    J Affect Disord; 2012 Dec; 143(1-3):179-86. PubMed ID: 22835850
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Toward a functional neuroanatomy of dysthymia: a functional magnetic resonance imaging study.
    Ravindran AV; Smith A; Cameron C; Bhatla R; Cameron I; Georgescu TM; Hogan MJ
    J Affect Disord; 2009 Dec; 119(1-3):9-15. PubMed ID: 19351572
    [TBL] [Abstract][Full Text] [Related]  

  • 85. High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication.
    Byers AL; Yaffe K; Covinsky KE; Friedman MB; Bruce ML
    Arch Gen Psychiatry; 2010 May; 67(5):489-96. PubMed ID: 20439830
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Amygdala enlargement in dysthymia--a volumetric study of patients with temporal lobe epilepsy.
    Tebartz van Elst L; Woermann FG; Lemieux L; Trimble MR
    Biol Psychiatry; 1999 Dec; 46(12):1614-23. PubMed ID: 10624542
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dysthymia: clinical and external validity.
    Akiskal HS
    Acta Psychiatr Scand Suppl; 1994; 383():19-23. PubMed ID: 7942064
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chemical & biological therapeutic approaches to neurological disorders.
    François I
    Drug News Perspect; 2010 Oct; 23(8):524-31. PubMed ID: 21031169
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Depression subtyping: treatment implications.
    Clayton PJ
    J Clin Psychiatry; 1998; 59 Suppl 16():5-12; discussion 40-2. PubMed ID: 9796860
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prognosis of depressive disorders in the general population- results from the longitudinal Finnish Health 2011 Study.
    Markkula N; Härkänen T; Nieminen T; Peña S; Mattila AK; Koskinen S; Saarni SI; Suvisaari J
    J Affect Disord; 2016 Jan; 190():687-696. PubMed ID: 26600410
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up.
    Rafanelli C; Milaneschi Y; Roncuzzi R; Pancaldi LG
    Psychosomatics; 2010; 51(1):8-13. PubMed ID: 20118435
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Systematic review and meta-analysis of the prevalence of depressive symptoms, dysthymia and major depressive disorders among homeless people.
    Ayano G; Belete A; Duko B; Tsegay L; Dachew BA
    BMJ Open; 2021 Feb; 11(2):e040061. PubMed ID: 33622940
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Refining a complex diagnostic construct: subtyping Dysthymia with the Shedler-Westen Assessment Procedure-II.
    Huprich SK; Defife J; Westen D
    J Affect Disord; 2014 Jan; 152-154():186-92. PubMed ID: 24120405
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Dysthymia and chronic depression: introduction, classification, risk factors, and course.
    Klein DN; Santiago NJ
    J Clin Psychol; 2003 Aug; 59(8):807-16. PubMed ID: 12858423
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Depressive personality traits and dysthymia: a commentary on Ryder and Bagby.
    Widiger TA
    J Pers Disord; 1999; 13(2):135-41. PubMed ID: 10372347
    [No Abstract]   [Full Text] [Related]  

  • 97. Oral contraceptives, depressive and insomnia symptoms in adult women with and without depression.
    Morssinkhof MWL; Lamers F; Hoogendoorn AW; de Wit AE; Riese H; Giltay EJ; van den Heuvel OA; Penninx BW; Broekman BFP
    Psychoneuroendocrinology; 2021 Nov; 133():105390. PubMed ID: 34425359
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Treating dysthymia and minor depression in primary care.
    David AK
    Postgrad Med; 2003 Nov; 114(5 Suppl Treating):19-25. PubMed ID: 19667640
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.
    Aydemir O; Deveci A; Taskin OE; Taneli F; Esen-Danaci A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1023-6. PubMed ID: 17433517
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Secular trends in the incidence of major depressive disorder and dysthymia in China from 1990 to 2019.
    Li M; Gao W; Zhang Y; Luo Q; Xiang Y; Bao K; Zaki N
    BMC Public Health; 2023 Nov; 23(1):2162. PubMed ID: 37926849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.